Pages Navigation Menu
Call Us: (800) 998-0500

From Our Blog

Fertility and Germline Stem Cell Transplants in Mice

Posted on Sep 15, 2017 in Blog

lab mouseFor many couples, conceiving a child can be a long and difficult process. The CDC estimates that 6.7% of married women aged 15-44 are infertile, meaning that they have not been able to get pregnant in over 12 months of attempting.  Further, 12.1% of women aged 15-44 have impaired fecundity, meaning that they have physical difficulty getting pregnant or carrying a pregnancy to live birth.

Causes of these fertility issues can include serious medical issues such as early menopause or chemo-induced infertility. One of the dream treatments for these conditions involves using germline stem cells. Germline stem cells are the precursors to both eggs and sperm. Until recently, the conventional wisdom was that women are born with a certain number of germline stem cells that all convert into eggs before she is born. However, there is now some evidence that germline stem cells may be able to be introduced to the body and be coaxed into developing into eggs.

Read More

Living Antibiotics: The New Last Line of Defense?

Posted on Aug 15, 2017 in Blog

When Alexander Fleming discovered penicillin in 1928, it started a new era in medicine: the era of antibiotics. Once penicillin could be efficiently purified in bulk in the 1940’s, it gave doctors access to an incredibly powerful tool to cure previously deadly diseases such as pneumonia and gonorrhea. However, antibiotics did not quite turn out to be a class of miracle drugs. Over time, many bacteria have been able to able to adapt to antibiotic treatment and develop resistance to the drugs. This has created an arms race between pharmaceutical companies and bacteria; as bacteria strains become resistant to antibiotics, drug companies must work to develop new medicines to fight them. In some cases, the bacteria seem to be winning. According to the CDC, more than 2 million people are infected by antibiotic-resistant bacteria in the US annually and 23,000 people die from drug-resistant infections every year. Most of these bacteria are only resistant to certain classes of antibiotics, although there have been almost 10 cases of totally-resistant bacteria in the US so far.

While the number of cases of bacteria that are completely resistant to all known antibiotic drugs is low, this is a nightmare scenario for health care. To develop a new last line of defense against antibiotic-resistant strains, researchers are looking to fight bacteria with…other bacteria. The plan is to harness bacteria that naturally prey on other bacteria, and use these predators to attack infections within the human body. Scientists are studying a strain of bacteria called Bdellovibrio bacteriovorus to this end. B. bacteriovorus attacks “gram-negative” bacteria, i.e. bacteria that have both an inner cell membrane and an outer cell wall. Many of the most dangerous antibiotic-resistant bacterial strains are gram-negative, such as the Enterobacteriaceae family (which includes pathogens such as Salmonella and E. coli) including Shigella spp (which causes dysentery).

Read More

Serotonin, Nerve Cell Wiring, and Depression

Posted on Jun 29, 2017 in Blog


Model of a Serotonin Molecule

Depression, or major depressive disorder (MDD) as it is known clinically, is one of the most common debilitative disorders on the planet. In 2015, it’s estimated that 216 million people (about 3% of the world population) suffered from depression. In the United States, depression is the leading cause of disability for people between the ages of 15 and 44. According to the Anxiety and Depression Association of America, MDD affects more than 15 million Americans annually – 6.7% of the adult population. Depression is believed to be caused by some combination of genetic, environmental, and psychological factors. However, the specific cause of the condition remains unknown.

In the past, the brain’s serotonin-delivery (serotonergic) system has been suspected to be involved with many psychiatric conditions, including depression. Serotonin is a chemical produced primarily in the gastrointestinal tract, but also plays a role in the function of the nervous system. It is thought to play a part in feelings of happiness, well-being, etc. Serotonin that gets used by the nervous system is predominantly managed in a part of the brain called the Raphe nuclei, which is in the brainstem. There aren’t many serotonergic cells in this area (only about 300,000), but they can deliver serotonin to the rest of the brain through a complex system of axons. Most studies of the causes of depression have focused on how serotonin is created and processed chemically in the brain when looking for causal links. However, a new study looks at how the axons that deliver the chemical spread out through the brain and what genes effect their development.

Read More

Modifying Mosquitoes for Genetic Sterility

Posted on Jun 2, 2017 in Blog

Aedes aegypti mosquitoDengue fever is one of the most pressing threats to global health. The World Health Organization considers it the most critical mosquito-borne virus. The symptoms include sudden-onset fever, headache (usually located behind the eyes), muscle and joint pains (thus the moniker “breakbone fever”), and a rash. The virus is spreading rapidly, with infection rates increasing by a factor of thirty over the last fifty years. More than 2.5 billion people in over 100 countries are at risk. While a vaccine for dengue fever was introduced in 2016, it is not 100% effective and researchers are still looking at novel ways to prevent infection.

One of the new approaches to prevent infection involves releasing bacterially-infected mosquitoes into the wild to crash the local population. This approach has been tested before, which we briefly mentioned in our blog about Zika last year. The method uses Wolbachia bacteria to control the population. Wolbachia is one of the most common parasitic microbes on the planet. They infect arthropods, including a high proportion of insects such as mosquitoes.

Read More

The Need for Climate-Friendly Refrigerants & Technologies

Posted on Apr 28, 2017 in Blog

1,1,1,2-tetrafluoroethane/R-134aEver since the development of vapor-compression refrigeration in the early 20th century, chemists have constantly been tinkering to find more efficient and cost-effective refrigerants. Until the late 1980’s, the most common refrigerants were chlorofluorocarbons, or CFCs. CFCs are organic compounds made up of carbon, chlorine, and fluorine (derived from methane, ethane, and propane), and are best known by their DuPont brand name: Freon. However, CFCs were found to be contributing to the depletion of the ozone layer, and in 1987 the multi-national Montreal Protocol on Substances that Deplete the Ozone Layer was agreed upon, which involved phasing out CFCs as refrigerants.

As CFCs were phased out throughout the 1990s, their primary replacements as refrigerant were hydrofluorocarbons, or HFCs. HFCs contain hydrogen atoms instead of the chlorine atoms found in CFCs. One of the most prolific HFCs, 1,1,1,2-tetrafluoroethane (known more commonly as R-134a), is used by Powers Scientific in all our refrigerated chambers. HFCs are an upgrade over CFCs in that they are much less destructive to the ozone layer. However, they are not a perfect solution. As concerns about climate change continue to grow, HFCs have come under scrutiny for their global warming potential (GWP). As the levels of HFCs in the atmosphere continue to increase, so does the climate risk. To keep this emergent environmental danger in check, world leaders met in Rwanda last October to make a deal to lower HFC usage. They agreed to lower the worldwide usage of HFCs by 80-85% by 2047.

Read More